Nu Skin Enterprises stock gained 1.32 percent as estimates weaken

Published on 10/05/2026 at 09:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nu Skin Enterprises stock closed at USD 4.61 on October 2, 2026, above its USD 4.45 52-week low. First-half revenue fell 14.6 percent year over year.

NUS, US67018T1051, Illustration mit AI erstellt.

Nu Skin Enterprises stock (ISIN US67018T1051) gained 1.32 percent and closed at USD 4.61 on the NYSE on October 2, 2026. The move came as the next quarterly estimate pointed to USD 328.7 million in revenue and adjusted earnings pressure remained central to the investment case.

Q2 loss overshadows revenue trend

Yahoo Finance lists Q2 FY26 revenue of USD 320.11 million and earnings of negative USD 249.8 million. The reported profit margin was negative 78.03 percent for the quarter, while actual EPS of USD 0.20 matched the listed estimate of USD 0.20.

Direct Selling Magazine reported on September 22, 2026, that first-half revenue reached USD 640.7 million, down from USD 750.6 million in the year-earlier period. That 14.6 percent decline and a first-half loss of USD 248.0 million define the latest reported operating picture.

Guidance sets the next test

Nu Skin lists its August 10, 2026 Q2 results among the latest quarterly disclosures. The company updated its 2026 outlook to revenue of USD 1.28 billion to USD 1.35 billion and adjusted EPS of USD 0.70 to USD 0.90, according to the September 22 report from Direct Selling Magazine.

The forecast also places the coming quarter against a weaker comparison base: Yahoo Finance shows a USD 328.7 million revenue estimate for September 2026 versus USD 364.21 million a year earlier, a decline of 9.75 percent. The corresponding GAAP EPS estimate is USD 0.21 versus USD 0.34, a decline of 38.24 percent.

Sell rating meets low valuation

MarketBeat lists a Sell consensus based on 2 research reports. Its page also places the company in personal care products, a category where Nu Skin combines beauty devices, skin-care products and nutritional supplements with direct selling.

For investors, the contrast is stark: the October 2 close was USD 4.61 against a 52-week range of USD 4.45 to USD 11.67, while the October 2 volume reached 376,367 shares. Market capitalization stood at USD 223.8 million, keeping the balance between restructuring potential and declining sales at the center of the valuation discussion.

NUS stock closed at USD 4.61

NUS stock closed at USD 4.61 on the NYSE on October 2, 2026, after a prior close of USD 4.55. The session range was USD 4.52 to USD 4.66, and the market capitalization was USD 223.8 million.